Zymeworks Bc Inc.: Clinical Trials

2 trials sponsored by Zymeworks Bc Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Recruiting 1

Follow Zymeworks Bc Inc.: new trials by email

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase 2 Single-Arm Open-Label Pilot Trial Evaluating Zanidatamab (ZW25) in Patients With Early Stage HER2/Neu Positive (HER2+) Breast Cancer (BC)
Zanidatamab, Letrozole, Tamoxifen - Breast Cancer, HER2-positive
Phase 2RecruitingM.D. Anderson Cancer Center202021-11-162026-08-24
ZW25 in Women With Endometrial Cancers
ZW25 - Endometrial Cancer, Carcinosarcoma
Phase 2CompletedMemorial Sloan Kettering Cancer Center162020-08-122025-05-22

Conditions studied

Breast Neoplasms (1)  ·  Carcinosarcoma (1)  ·  Endometrial Neoplasms (1)

Interventions

Letrozole (1)  ·  Tamoxifen (1)  ·  zanidatamab (1)

Countries

United States (2)

Top investigators

Vicente Valero (1)  ·  Vikky Makker, MD (1)

Results publications

PMID 38262242, PMID 42773107